|
UTP14A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.451000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.075600E-01 |
| Normal-vs-Stage2 |
8.694400E-01 |
| Normal-vs-Stage3 |
5.159000E-01 |
| Normal-vs-Stage4 |
8.007400E-01 |
| Stage1-vs-Stage2 |
6.349400E-01 |
| Stage1-vs-Stage3 |
2.184600E-01 |
| Stage1-vs-Stage4 |
9.769200E-01 |
| Stage2-vs-Stage3 |
7.011600E-01 |
| Stage2-vs-Stage4 |
7.180800E-01 |
| Stage3-vs-Stage4 |
3.860000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.266800E-01 |
| Normal-vs-AfricanAmerican |
4.866800E-01 |
| Normal-vs-Asian |
5.690600E-01 |
| Caucasian-vs-AfricanAmerican |
6.380400E-01 |
| Caucasian-vs-Asian |
7.177600E-01 |
| AfricanAmerican-vs-Asian |
8.096000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.697800E-01 |
| Normal-vs-Female |
8.289400E-01 |
| Male-vs-Female |
5.294200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.501800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.242000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.738000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.101000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.350760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.753400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.416980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.704000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.359600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.934800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.068200E-01 |
| Classical-VS-Follicular |
4.30020000000697E-05 |
| Classical-VS-Other |
7.259200E-01 |
| Classical-VS-Normal |
2.209200E-01 |
| Tall-VS-Follicular |
1.502790E-01 |
| Tall-VS-Other |
9.810400E-01 |
| Tall-VS-Normal |
7.882400E-01 |
| Follicular-VS-Other |
4.341400E-01 |
| Follicular-VS-Normal |
2.163800E-02 |
| Other-VS-Normal |
9.489800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.902200E-01 |
| Normal-vs-N1 |
5.311600E-01 |
| N0-vs-N1 |
8.001800E-01 |
|
|
